1. Home
  2. RVNC vs BLDE Comparison

RVNC vs BLDE Comparison

Compare RVNC & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • BLDE
  • Stock Information
  • Founded
  • RVNC 1999
  • BLDE 2014
  • Country
  • RVNC United States
  • BLDE United States
  • Employees
  • RVNC N/A
  • BLDE N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • BLDE Aerospace
  • Sector
  • RVNC Health Care
  • BLDE Consumer Discretionary
  • Exchange
  • RVNC Nasdaq
  • BLDE Nasdaq
  • Market Cap
  • RVNC 292.5M
  • BLDE 284.6M
  • IPO Year
  • RVNC 2014
  • BLDE N/A
  • Fundamental
  • Price
  • RVNC $3.58
  • BLDE $3.45
  • Analyst Decision
  • RVNC Buy
  • BLDE Strong Buy
  • Analyst Count
  • RVNC 9
  • BLDE 3
  • Target Price
  • RVNC $12.00
  • BLDE $9.33
  • AVG Volume (30 Days)
  • RVNC 1.8M
  • BLDE 569.9K
  • Earning Date
  • RVNC 08-06-2024
  • BLDE 08-07-2024
  • Dividend Yield
  • RVNC N/A
  • BLDE N/A
  • EPS Growth
  • RVNC N/A
  • BLDE N/A
  • EPS
  • RVNC N/A
  • BLDE N/A
  • Revenue
  • RVNC $236,645,000.00
  • BLDE $231,423,000.00
  • Revenue This Year
  • RVNC $20.63
  • BLDE $11.83
  • Revenue Next Year
  • RVNC $34.80
  • BLDE $13.62
  • P/E Ratio
  • RVNC N/A
  • BLDE N/A
  • Revenue Growth
  • RVNC 54.59
  • BLDE 40.46
  • 52 Week Low
  • RVNC $2.30
  • BLDE $2.06
  • 52 Week High
  • RVNC $24.87
  • BLDE $4.54
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 69.18
  • BLDE 58.12
  • Support Level
  • RVNC $2.40
  • BLDE $3.35
  • Resistance Level
  • RVNC $2.75
  • BLDE $3.53
  • Average True Range (ATR)
  • RVNC 0.23
  • BLDE 0.15
  • MACD
  • RVNC 0.13
  • BLDE 0.02
  • Stochastic Oscillator
  • RVNC 91.43
  • BLDE 78.22

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Share on Social Networks: